All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-17652471

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	17652471	A1762T	BCP		Carcinoma, Hepatocellular	G S C L	View
2	17652471	C1485T	X	X	Carcinoma, Hepatocellular	G S C L	View
3	17652471	C1653T	Core Promoter		Carcinoma, Hepatocellular	G S C L	View
4	17652471	G1499H	X	X	Carcinoma, Hepatocellular	G S C L	View
5	17652471	G1613A	X	X	Carcinoma, Hepatocellular	G S C L	View
6	17652471	G1764A	BCP		Carcinoma, Hepatocellular	G S C L	View
7	17652471	G1896A	PreC	C	Carcinoma, Hepatocellular	G S C L	View
8	17652471	T1479C	X	X	Carcinoma, Hepatocellular	G S C L	View
9	17652471	P38S	X	X	Carcinoma, Hepatocellular	G S C L	View
10	17652471	T36P	X	X	Carcinoma, Hepatocellular	G S C L	View
11	17652471	T1753V	BCP		Carcinoma, Hepatocellular	G S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.